The Natural History of Alpha-Mannosidosis

Study Identifier:
rhLAMAN-01
ClinicalTrials.gov Identifier:
NCT00498420
EudraCT Identifier:
N/A
Study Contact Information:
N/A
See Study Publication Below
Study Complete

Study Details

Medical Condition
  • Alphamanosidosis
Study Drug
    Date
    May 2007 - Sep 2009
    Phase 1
    Phase 2
    Phase 3
    Phase 4
    N/A
    Patient Requirements
    Sex: Female & Male
    Age: N/A
    Requirements Information
    Healthy Volunteers
    No

    Protocol Summary

    The natural history study of the rare lysosomal disease alpha-mannosidosis will answer the question; why the rare disease develops as it does?

    Study Locations

    Location
    Status
    Location
    Department of Pediatrics, Charles University
    Prague, Czech Republic, 12000 Prague
    Status
    N/A
    Location
    University of Mainz
    Mainz, Germany, 55101
    Status
    N/A
    Location
    Department of Medicine, University of Tromsoe
    Tromsoe, Norway, N-9038
    Status
    N/A
    Location
    Willink Biochemical Genetics Unit,. Royal Manchester Children's Hospital
    Manchester, United Kingdom, M27 4HA
    Status
    N/A

    Study Publications

    Beck M, Olsen KJ, Wraith JE, Zeman J, Michalski JC, Saftig P, Fogh J, Malm D. Natural history of alpha mannosidosis a longitudinal study. Orphanet J Rare Dis. 2013 Jun 20;8:88. doi: 10.1186/1750-1172-8-88.Borgwardt L, Stensland HM, Olsen KJ, Wibrand F, Klenow HB, Beck M, Amraoui Y, Arash L, Fogh J, Nilssen O, Dali CI, Lund AM. Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation. Orphanet J Rare Dis. 2015 Jun 6;10:70. doi: 10.1186/s13023-015-0286-x.